Hovione
Paulo Roque Lino, PharmD, PhD has extensive experience in the pharmaceutical industry, with a focus on metabolism, genetics, nanomedicine, and drug delivery systems. Currently holding the position of Senior Scientist at Hovione, Paulo previously worked as a Post-Doc and PhD student at iMed.ULisboa. With a strong educational background, including a Ph.D. in Pharmaceutical Sciences from the University of Lisbon, Paulo has a solid foundation in the field of pharmaceutical research and development. Throughout their career, Paulo has demonstrated a commitment to advancing pharmaceutical science and making significant contributions to the industry.
This person is not in any offices
Hovione
2 followers
Hovione is an international company with over 60 years of experience in pharmaceutical development and manufacturing operations. As a Contract Development and Manufacturing Organization (CDMO) with a fully integrated offering of services for drug substances, drug product intermediates and drug products. The company has four FDA inspected sites in the USA, Portugal, Ireland and China and development laboratories in Lisbon, Portugal and New Jersey, USA. Hovione provides pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including highly potent compounds, and customized product solutions across the entire drug life cycle. In the inhalation area, Hovione offers a complete range of services, from API, formulation development and devices. Hovione´s culture is based on innovation, quality and dependability. Hovione was the first Chemical/ Pharmaceutical Company to become a Certified B Corp, is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards.